ELUCIDATING MOLECULAR MECHANISMS OF TUMOR-IMMUNE DYNAMICS AND EVOLUTION IN RESPONSE TO RADIATION TO OPTIMIZE TREATMENT OF HIGH- AND VERY HIGH-RISK PROSTATE CANCER
$1,498,368FY2025Defense Health AgencyDOD
The General Hospital Corporation
The General Hospital Corporation